discovered that ARL5B was a key oncogene in esophageal squamous cell carcinoma (ESCC), promoting ESCC cell proliferation, invasion, and tumor growth in vivo, and potentially serving as a regulatory mechanism for lipid metabolism (48). Here, ARL5B is linked to esophageal squamous cell carcinoma.